Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications.
Background Daclizumab is a humanized monoclonal antibody (mAb) that blocks the interleukin-2 receptor alpha subunit (IL-2R-alpha chain; CD25) expressed on activated T cells leading to the inhibition… (More)
AbstractBackground: Rituximab is a monoclonal antibody approved for treating CD20-positive B-cell non-Hodgkin’s lymphoma and rheumatoid arthritis but is used off-label for treating many autoimmune… (More)
This paper presents a noise resistant, auto calibrated all digital temperature sensor for circuit protection applications. The sensor uses a variable pulse-based design, allowing… (More)
Natalizumab is a monoclonal antibody, representing a new class of medication for treating relapsing multiple sclerosis (MS). Conventional treatments include interferons, glatiramer acetate and… (More)